background
preval
respiratori
virus
adult
larg
underexplor
studi
focu
children
addit
sever
ill
immunocompromis
adult
respiratori
infect
mostli
attribut
bacteria
fungi
respiratori
virus
lead
sever
complic
object
evalu
epidemiolog
respiratori
virus
bronchoalveolar
lavag
fluid
bal
specimen
patient
lower
respiratori
tract
diseas
studi
popul
consist
differ
group
includ
immunocompet
patient
control
patient
solid
organ
transplant
recipi
patient
haematolog
malign
immunocompromis
adult
studi
design
total
bal
fluid
specimen
collect
retrospect
assess
new
commerci
multiplex
realtim
pcr
ftd
respiratori
plu
target
differ
virus
atyp
bacteri
pathogen
result
viral
atyp
bacteri
pathogen
detect
bal
fluid
specimen
coronavirus
preval
follow
rhinovirus
rsv
bocavirus
compar
total
number
virus
detect
statist
signific
differ
observ
control
group
patient
haematolog
malign
vs
p
conclus
conclus
studi
highlight
high
preval
respiratori
virus
bal
fluid
specimen
adult
patient
lower
respiratori
tract
diseas
method
use
sensit
cover
wide
rang
potenti
pathogen
specif
patient
popul
also
influenc
detect
rate
respiratori
virus
respiratori
syncyti
viru
rsv
influenza
flu
adenovirus
adv
human
metapneumoviru
hmpv
parainfluenza
virus
human
rhinovirus
hrv
consid
import
pathogen
aetiolog
respiratori
infect
past
decad
improv
detect
techniqu
contribut
increas
sensit
discoveri
new
respiratori
virus
hmpv
novel
strain
coronavirus
sarshcov
hcovhkui
mersviru
human
bocaviru
hbov
novel
polyomavirus
wu
ki
howev
preval
respiratori
virus
adult
still
larg
underexplor
studi
focu
children
sever
ill
immunocompromis
adult
respiratori
virus
also
lead
sever
complic
present
studi
evalu
epidemiolog
respiratori
virus
bronchoalveolar
lavag
fluid
bal
specimen
patient
lower
respiratori
tract
diseas
inand
outpati
use
new
commerci
qualit
multiplex
realtim
pcr
ftd
respiratori
plu
fasttrack
diagnost
junglinst
luxembourg
target
differ
virus
atyp
bacteri
pathogen
addit
assess
epidemiolog
respiratori
virus
differ
patient
popul
high
risk
complic
includ
solid
organ
transplant
recipi
patient
haematolog
malign
immunocompromis
condit
total
bal
fluid
specimen
patient
admit
univers
hospit
ghent
lower
respiratori
tract
infect
three
consecut
respiratori
season
analys
bronchoscopi
perform
team
pulmonologist
follow
standardis
protocol
ml
steril
salin
solut
instil
time
distal
bronchial
tree
maxim
recoveri
instil
volum
gram
stain
perform
evalu
sampl
qualiti
magnif
direct
identif
bacteria
fungi
sampl
store
c
retrospect
analys
spring
commerci
multiplex
realtim
pcr
ftd
respiratori
plu
subject
enrol
differ
patient
popul
accord
underli
condit
six
group
defin
immunosuppress
condit
control
group
ii
acut
myeloid
leukaemia
aml
iii
haematopoiet
stem
cell
transplant
recipi
iv
haematolog
malign
v
solid
organ
transplant
recipi
vi
immunosuppress
condit
detail
composit
diseas
group
see
tabl
patient
age
rang
year
subject
year
year
older
year
adult
year
ftd
respiratori
plu
use
accord
manufactur
instruct
fasttrack
diagnost
junglinst
luxembourg
follow
total
nucleic
acid
extract
perform
nuclisen
easymag
tm
lyon
franc
allow
simultan
detect
identif
follow
respiratori
virus
flu
separ
detect
influenza
flu
b
flu
hrv
hcov
piv
hmpv
hbov
adv
rsv
enterovirus
hev
parechovirus
hpev
chlamydophila
pneumonia
cpp
mycoplasma
pneumonia
mpp
evalu
ftd
respiratori
plu
assay
descript
perform
characterist
ad
supplementari
file
data
analys
use
medcalc
medcalc
softwar
mariakerk
belgium
comparison
proport
chisquar
use
compar
detect
rate
differ
popul
result
p
consid
signific
viral
atyp
bacteri
pathogen
detect
bal
fluid
specimen
rang
differ
respiratori
season
singl
pathogen
found
sampl
wherea
infect
multipl
pathogen
less
frequent
observ
sampl
patient
two
differ
virus
detect
concomitantli
wherea
three
virus
detect
patient
total
bal
fluid
specimen
viral
distribut
genu
level
follow
hcov
hku
tabl
epidemiolog
respiratori
virus
bal
fluid
specimen
differ
patient
group
present
tabl
viral
pathogen
detect
bal
fluid
specimen
control
group
compar
total
diseas
group
statist
signific
compar
proport
posit
bal
sampl
control
group
differ
patient
popul
statist
signific
differ
observ
patient
haematolog
malign
vs
p
singl
infect
frequent
observ
control
group
compar
diseas
group
vs
statist
signific
addit
compar
total
number
virus
detect
control
group
differ
patient
popul
statist
signific
differ
observ
patient
haematolog
malign
vs
p
haematolog
malign
vs
p
preval
respiratori
virus
adult
larg
underexplor
studi
focu
infant
children
present
studi
respiratori
virus
recov
bal
fluid
specimen
rang
differ
year
report
detect
rate
respiratori
viral
infect
use
molecular
assay
rang
line
find
differ
explain
heterogen
includ
popul
specimen
type
number
virus
simultan
test
method
use
import
specimen
type
highlight
sever
studi
bal
specimen
diagnost
yield
rang
report
soccal
et
al
evalu
pair
nasopharyng
bal
fluid
specimen
observ
overal
viral
posit
rate
upper
respiratori
tract
specimen
bal
sampl
p
composit
studi
popul
major
influenc
observ
detect
rate
garbino
et
al
assess
preval
respiratori
virus
differ
group
hospitalis
tabl
epidemiolog
respiratori
virus
bal
fluid
specimen
differ
patient
group
adult
posit
rate
rang
immunocompet
patient
vs
transplant
popul
lung
transplant
exclud
studi
patient
haematolog
malign
compris
substanti
proport
popul
statist
signific
differ
viral
posit
rate
compar
immunocompet
popul
vs
p
import
respiratori
virus
patient
haematolog
malign
well
known
addit
virus
cytomegaloviru
epsteinbarr
viru
evalu
potenti
pathogen
hcov
hrv
frequent
encount
current
studi
repres
respect
found
unexpectedli
rather
high
preval
hcov
adult
comparison
literatur
around
mostli
throat
nose
swab
vs
around
mostli
bal
fluid
abil
commoncold
virus
includ
hcov
hrv
caus
lower
respiratori
tract
diseas
pneumonia
previous
report
well
known
exampl
sarshcov
caus
sever
acut
respiratori
infect
human
respons
global
outbreak
conclus
studi
highlight
high
preval
respiratori
virus
bal
fluid
specimen
adult
patient
lower
respiratori
tract
infect
studi
investig
patient
group
import
investig
clinic
outcom
need
fulli
understand
valu
detect
respiratori
virus
bal
fluid
specimen
adult
patient
lower
respiratori
tract
diseas
none
